Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,647 | -4,228 | -3,346 | -2,236 | -1,031 |
| Depreciation Amortization | 30 | 11 | 9 | 6 | 3 |
| Other Working Capital | -61 | -1,184 | -1,125 | -709 | -609 |
| Other Operating Activity | 856 | 739 | 582 | 13 | -3 |
| Operating Cash Flow | $-823 | $-4,661 | $-3,881 | $-2,926 | $-1,640 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,219 | 1,316 | 1,316 | 905 |
| PPE Investments | 45 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -19 | N/A | -77 | -56 | -34 |
| Purchase Sale Intangibles | -50 | -575 | -75 | N/A | N/A |
| Other Investing Activity | -50 | -575 | -75 | 0 | 0 |
| Investing Cash Flow | $-24 | $644 | $1,164 | $1,260 | $871 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 4,860 | 2,729 | 2,094 | N/A |
| Financing Cash Flow | $N/A | $4,860 | $2,729 | $2,094 | $N/A |
| Beginning Cash Position | 4,749 | 3,906 | 3,906 | 3,906 | 3,906 |
| End Cash Position | 3,903 | 4,749 | 3,918 | 4,334 | 3,137 |
| Net Cash Flow | $-846 | $843 | $12 | $428 | $-769 |
| Free Cash Flow | |||||
| Operating Cash Flow | -823 | -4,661 | -3,881 | -2,926 | -1,640 |
| Free Cash Flow | -823 | -4,661 | -3,881 | -2,926 | -1,640 |